Thursday, March 28, 2024

Serum Institute of India

Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield

By PTI NEW DELHI: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of the Covid-19 vaccine Covishield amid...

COVID-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla 

By PTI PUNE: Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster...

India’s first vaccine against cervical cancer to launch on September 1

By ANI NEW DELHI: The Serum Institute of India (SII) and the Department of Biotechnology(DBT) are set to launch India's first indigenously developed Quadrivalent...

Drug controller allows sale of Serum Institute’s cervical cancer vaccine

By Express News Service NEW DELHI: The Drugs Controller General of India (DCGI) on Tuesday granted market authorisation to the Serum Institute of India...

Panel for emergency use approval to SII vaccination for 7-11 age group

By Express News Service NEW DELHI:  An expert panel advising the Central Drugs Standard Control Organisation (CDSCO) has recommended granting emergency use authorisation to...

Government panel recommends market authorisation for SII’s qHPV vaccine against cervical cancer

By PTI NEW DELHI: An expert panel of India's central drug authority on Wednesday recommended granting of market authorisation to Serum Institute of India...

Millions of COVID vaccines unsold; stopped production since December 2021: Adar Poonawalla

By PTI MUMBAI: The Serum Institute of India has stopped producing the COVID-19 vaccine since the last day of December 2021 as it has...

Serum Institute, Bharat Biotech cut COVID vaccine prices for private hospitals to Rs 225

By PTI NEW DELHI: Vaccine majors Serum Institute of India (SII) and Bharat Biotech on Saturday said they have decided to cut prices of...

DCGI’s EUA nod to SII’s Covovax for 12-17 years age group

By PTI NEW DELHI: India's drug regulator has granted restricted emergency use authorisation to Serum Institute's COVID-19 vaccine Covovax for the 12-17 years age...

Government expert panel recommends regular market approval for Covishield, Covaxin

By PTI NEW DELHI: An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to Covid vaccines Covishield and...

Latest News

The wait of the fans is over, the release date of Heeramandi has been announced…

People are eagerly waiting for director Sanjay Leela Bhansali's film 'Heeramandi: The Diamond Bazaar'. #HeeramandiKabReleaseHogi is also trending...